超声造影与增强CT鉴别良恶性小肾实性肿块的比较
该研究纳入118例经病理证实的<4 cm小肾肿块患者(良性25例、恶性93例),回顾性比较超声造影与增强CT的诊断效能,两种方法各诊断指标间无统计学显著差异,但超声造影对小乳头状肾细胞癌的定性诊断显著优于增强CT。
要点
- 超声造影与增强CT鉴别良恶性小肾肿块各诊断指标间无统计学显著差异(P>0.05)。
- 超声造影对小乳头状肾细胞癌的定性诊断显著优于增强CT(P<0.05)。
- 超声造影与增强CT的观察者间一致性加权kappa值分别为0.89和0.93。
核心结论
- 超声造影与增强CT均能有效鉴别良恶性小肾实性肿块,且超声造影对小乳头状肾细胞癌的定性诊断可能更有效。
研究设计与样本
- 回顾性研究,纳入118例患者共118个经手术切除后组织病理学证实的<4 cm肾脏肿块(良性25个、恶性93个),由两名超声医师和两名放射科医师在不知晓CT或超声结果及最终组织学结果的情况下独立阅片,采用3分法评分(1分为良性、2分为不确定、3分为恶性),以加权kappa统计量评价观察者间一致性。
诊断标准与关键数值
- 超声造影诊断良恶性小肾肿块的敏感度为93.5%、特异度为68%、阳性预测值为91.6%、阴性预测值为73.9%、AUC为0.808。
- 增强CT诊断良恶性小肾肿块的敏感度为89.2%、特异度为76%、阳性预测值为93.3%、阴性预测值为65.5%、AUC为0.826。
- 超声造影观察者间一致性的加权kappa值为0.89(95%CI 0.79-0.98),增强CT为0.93(95%CI 0.87-0.99)。
- 两种方法各诊断效能指标间差异均无统计学显著意义(P>0.05)。
临床应用与阅片要点
- 超声造影与增强CT均可用于小肾实性肿块的良恶性鉴别诊断。
- 作者认为超声造影对小乳头状肾细胞癌的定性诊断可能比增强CT更有效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The study aimed to compare the diagnostic efficiency of contrast-enhanced ultrasound (CEUS) with that of contrast-enhanced computed tomography (CECT) in the evaluation of benign and malignant small renal masses (SRMs) (<4 cm) confirmed by pathology.
METHODS: A total of 118 patients with 118 renal masses smaller than 4 cm diagnosed by both CEUS and CECT were enrolled in this study, including 25 benign lesions and 93 malignant lesions. All lesions were confirmed by histopathologic diagnosis after surgical resection. The diagnostic imaging studies of the patients were retrospectively reviewed by two independent ultrasonologists and two independent radiologists blinded to the CT or ultrasound findings and final histological results. All lesions on both CEUS and CECT were independently scored on a 3-point scale (1: benign, 2: equivocal, and 3: malignant). The concordance between interobserver agreement was interpreted using a weighted kappa statistic. The diagnostic efficiency of the evaluation of benign and malignant lesions was compared between CEUS and CECT.
RESULTS: All the 118 included lesions were detected by both CEUS and CECT. In CEUS and CECT imaging evaluation of the 118 lesions, the weighted kappa value interpreting the concordance between interobserver agreement was 0.89 (95% CI 0.79-0.98) and 0.93 (95% CI 0.87-0.99), respectively. Both CEUS and CECT demonstrated good diagnostic performance in differential diagnosis of benign and malignant SRMs with sensitivity of 93.5% and 89.2%, specificity of 68% and 76%, PPV of 91.6% and 93.3%, NPV of 73.9% and 65.5%, and AUC of 0.808 and 0.826, respectively. There was no statistically significant difference in any of the diagnostic performance indices between these two methods (P > 0.05). However, the qualitative diagnosis of small papillary renal cell carcinoma (RCC) by CEUS was significantly better than that by CECT (P < 0.05), while there was no significant difference in qualitative diagnostic accuracy on other histotypes of SRMs between CEUS and CECT (P > 0.05).
CONCLUSIONS: Both CEUS and CECT imaging modalities are effective for the differential diagnosis of benign and malignant SRMs. Furthermore, CEUS may be more effective than CECT for the qualitative diagnosis of small papillary RCC.
引用
- Wei SP, Xu CL, Zhang Q, et al. Contrast-enhanced ultrasound for differentiating benign from malignant solid small renal masses: comparison with contrast-enhanced CT. Abdom Radiol (NY). 2017. PMID: 28331942. doi:10.1007/s00261-017-1111-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。